FRESHBURST LISTERINE ANTISEPTIC (Pfizer Consumer Healthcare)
Active Ingredients: Thymol 0.064%, Eucalyptol 0.092%, Methyl Salicylate 0.060% and Menthol 0.042%.
Inactive Ingredients: Water, Alcohol 21.6%, Sorbitol Solution, Flavoring, Poloxamer 407, Benzoic Acid, Sodium Saccharin, Sodium Benzoate, D&C Yellow No. 10, and FD&C Green No. 3.
Indications: Use FreshBurst Listerine Antiseptic twice daily to help:
- Prevent & Reduce Plaque
- Prevent & Reduce Gingivitis
- Fight Bad Breath
- Kill Germs Between Teeth
Actions: FreshBurst Listerine Antiseptic has been shown to help prevent and reduce supragingival plaque accumulation and gingivitis when used in a conscientiously applied program of oral hygiene and regular professional care. Its effect on periodontitis has not been determined. Listerine is the only leading nonprescription mouthrinse that has received the American Dental Association's Council on Scientific Affairs Seal of Acceptance for helping to prevent and reduce plaque and gingivitis.
Directions: Rinse full strength for 30 seconds with 20 ml ( 2 / 3 fl. ounce or 4 teaspoonfuls) morning and night. If bad breath persists, see your dentist.
Do not administer to children under twelve years of age. Keep this and all drugs out of the reach of children. Do not swallow. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately. Cold weather may cloud FreshBurst Listerine. Its antiseptic properties are not affected. Store at 59° to 77°F.
How Supplied: FreshBurst Listerine antiseptic is supplied in 250 ml, 500 ml, 1.0 liter, 1.5 liter bottles and 1.7 liter bottles, as well as 3 fl. oz. bottles. It is also available to professionals in 3 fl. oz. bottles and in gallon bottles.
PRODUCT PHOTO(S):NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.
The product samples shown here have been supplied by the manufacturer. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug's identity should be verified by chemical analysis.